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Abstract
During postnatal development, microglia, the resident innate immune cells of the central nervous system are constantly
monitoring the brain parenchyma, cleaning the cell debris, the synaptic contacts overproduced and also maintaining the
brain homeostasis. In this context, the postnatal microglia need some control over the innate immune response. One such
molecule recently described to be involved in modulation of immune response is TREM2 (triggering receptor expressed on
myeloid cells 2). Although some studies have observed TREM2 mRNA in postnatal brain, the regional pattern of the TREM2
protein has not been described. We therefore characterized the distribution of TREM2 protein in mice brain from Postnatal
day (P) 1 to 14 by immunostaining. In our study, TREM2 protein was expressed only in microglia/macrophages and is
developmentally downregulated in a region-dependent manner. Its expression persisted in white matter, mainly in caudal
corpus callosum, and the neurogenic subventricular zone for a longer time than in grey matter. Additionally, the
phenotypes of the TREM2+ microglia also differ; expressing CD16/32, MHCII and CD86 (antigen presentation markers) and
CD68 (phagocytic marker) in different regions as well as with different intensity till P7. The mannose receptor (CD206)
colocalized with TREM2 only at P1–P3 in the subventricular zone and cingulum, while others persisted at low intensities till
P7. Furthermore, the spatiotemporal expression pattern and characterization of TREM2 indicate towards its other plausible
roles in phagocytosis, progenitor’s fate determination or microglia phenotype modulation during postnatal development.
Hence, the increase of TREM2 observed in pathologies may recapitulate their function during postnatal development, as a
better understanding of this period may open new pathway for future therapies.
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Introduction
Microglia are the resident innate immune cells of the central
nervous system (CNS), ontogenically related to macrophages and
they derive from yolk sac to enter brain at early embryonic
development [1,2]; migrating through the brain following a
specific pattern [3]. While vascularization progresses, they locally
proliferate in the ‘fountains of microglia’ and populate all the
parenchyma during the first two weeks of life [4,5,6,7,8].
Concomitantly, the postnatal development comprises neuronal
and glial differentiation, dendritic arborization, axonal growth,
myelination, blood-brain barrier formation and neuronal circuits’
establishment, including new synaptic contacts formation. Mi-
croglia constantly survey the parenchyma [9,10], clean the cell
debris or synaptic contacts overproduced during postnatal
development and play an important role in maintaining the
homeostasis [11,12,13]. In the ongoing process, microglia display
distinct physiological and morphological features [7,14]; that
indeed is due to microglia being endowed with a plethora of
molecules that allow them to acquire diverse and complex
phenotypes [15,16,17,18,19].
The postnatal microglia need to control the innate immune
response in context to cellular death during development using
endogenous mechanisms regulating inflammatory cell activation,
including the expression of modulatory and/or inhibitory mem-
brane receptors. These receptors play a key role in the regulation
of inflammatory processes, mainly by cell-cell interaction with
neurons, such as CX3CR1-CX3CL1 [20], CD200R-CD200
[21,22,23], CD47-CD172a [24] and TREM2-HSP60 (as putative
endogenous receptor) [25,26,27], among others.
TREM2 (triggering receptor expressed on myeloid cells 2) is a
cell surface receptor expressed on osteoclast, dendritic cells,
macrophages, nature killers, neutrophils and microglia
[26,28,29,30,31]. Recently the expression of TREM2 in subpop-
ulation of neurons and oligodendrocytes has been described
[31,32,33]. TREM2 needs an adaptor protein DAP12 to initiate
the intracellular signalling cascade via an immunoreceptor
tyrosine-based activation motif (ITAM) domain and tyrosine-
kinases [28]. The complex TREM2/DAP12 had also been
associated with synaptic function [34,35]. In humans, the loss-of-
function of TREM2 or its coreceptor DAP12 is responsible for the
recessively inherited Nasu-Hakola disease (also known as Polycystic
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lipomembranous osteodysplasia with sclerosing leukoencephalopathy;
PLOSL), characterized by an early onset dementia associated
with bone cysts [36,37]. The brains of PLOSL affected patients
show strong microglial activation in the cerebral white matter,
substantial white matter atrophy in corpus callosum and basal
ganglia [36]. In addition, failure of TREM2 function in microglia
has been associated with the loss of homeostatic control [38,39].
Studies in vitro, using macrophages have shown that TREM2 is
down-regulated by inflammatory stimulus such as LPS [26] and is
induced by anti-inflammatory cytokine IL-4 [40]. Additionally,
TREM2 stimulation by lentiviral transgene expression in microg-
lial cells induced cytoskeletal reorganization and increased
phagocytosis, whereas knockdown of TREM2 induced a reduced
phagocytic ability and increased capacity to produce pro-
inflammatory molecules like TNF-alpha and iNOS [41]. Exper-
iments defining TREM2 function after CNS pathology have
shown that blockade of TREM2 in animal models of multiple
sclerosis leads to disease exacerbation by increasing leukocyte
infiltration and demyelination [42], while intravenous application
of TREM2-transduced myeloid cells facilitated repair by reducing
axonal damage [43]. Interestingly, recent experiments using a
mouse stroke model had shown an attenuated inflammatory
response in knock out animals compared to wild type [44], without
changes in injury size.
During the last few years, some groups have described the
TREM2 mRNA expression in embryonic and postnatal brain
[27,33]. However, the regional pattern and phenotype of cells
expressing functional TREM2-DAP12 during postnatal develop-
ment is still exiguous or missing. Moreover, the type of cells
expressing TREM2 is quite debatable. Hence, the aims of this
study was to analyze the regional and age dependent expression
pattern of TREM2 protein in postnatal brain by immunofluores-
cence. An emphasis was placed in the characterization of the
phenotype of the cell population expressing TREM2. The
temporal and regional modulation of TREM2 might give us the
basis for a better understanding of mechanisms involved in
neuropsychiatric and neurodegenerative disorders following peri-
natal brain injury or inflammation in future.
Materials and Methods
Animals
C57BL/6 mice (breaded in Harlan Labs, France) of different
postnatal ages were used for all the experiments. Animals were
maintained at constant temperature (2462uC) and housed on a
12:12 hours light-dark cycle with food and water ad libitum.
Experimental animal work was conducted in accordance with
Spanish regulations and the European Union directives on the use
of animals in scientific research. The protocol was specifically
approved by the Ethical Commission for Animal and Human
Experimentation of Autonomous University of Barcelona (proto-
col number 811). All efforts were made to minimize number and
suffering of animals used at each stage of experimentation.
Tissue Processing
C57BL/6 mice were sacrificed at postnatal day (P) 1, P3, P5,
P7, P10, P12 and P14. Animals from at least 3 different litters were
intraperitoneally anaesthetized (ketamine and xylacine 80/10 mg/
Kg) and intracardially perfused using 4% paraformaldehyde in
phosphate buffer saline (PBS, pH 7.4). Subsequently, brains were
removed, postfixed for 4 hrs in the same fixative, cryoprotected in
30% sucrose, frozen with dry CO2, and finally stored at 280uC
until use. Brains were serially cut in a cryostat (Leica CM3050 S)
into 30 mm thick coronal sections and stored mounted on Flex
IHC slides (K8020, Dako) at 220uC.
Immunohistochemistry for TREM2
Animals from each postnatal age group (n= 3–5) were processed
for the immunohistochemical demonstration of TREM2. Single
immunohistochemistry was initiated by blocking the endogenous
peroxidase (2% H2O2 in 70% methanol for 10 min) and
incubation for 1 h in blocking buffer (BB) containing 0.2%
gelatine (powder food grade, 1.04078, Merck) in Tris-buffered
saline (TBS, pH 7.4) with 0.3% Triton X-100 (TBST) at room
temperature (RT). Afterwards, slides were incubated overnight at
RT with the primary antibody diluted in BB (Table 1) and the
slides used as negative controls without primary antibody. In a
separate slide, TREM2 primary antibody was pre-blocked with
TREM2-Fc protein, as recommended by supplier (25x, 1729-T2,
R&D System) in order to ensure the specificity (no staining was
observed in these conditions). After washing with TBST, sections
were incubated with biotinylated anti-sheep antibody at RT for
1 h (Table 2); washed again and incubated with streptavidin–
peroxidase for 1 h (Table 2). The peroxidase reaction was
visualized by incubating the sections in 3,3-diaminobenzidine and
hydrogen peroxide using the DAB kit (SK-4100; Vector Labora-
tories, USA). Finally, sections were dehydrated and coverslipped in
DPX. Photography was performed using a DXM 1200F Nikon
digital camera joined to a Nikon Eclipse 80i microscope and plates
were arranged using Adobe Photoshop CS3.
Quantification of TREM2 in Postnatal Brain
Images from three sections/animal were taken, representing the
following regions: cingulate cortex (cx), subventricular zone (svz),
rostral and caudal corpus callosum (cc), caudate-putamen (cp),
hippocampal fissure (hf), fimbria (fim) and thalamus (tl) (Fig. 1A).
Micrographs were captured using the 406 objective. For P1, P3
and P5 photographs were taken from 2.43 to 2.79 mm and 3.39 to
3.75 mm (corresponding to Fig 57–60 and 65–68, respectively in
the Atlas of the Developing Mouse Brain [45]). From P7 onwards
regions were chosen as follows: from 3.03 to 3.27 mm and from
4.47 to 4.71 mm (corresponding to Fig 117–119 and 129–131,
respectively in the Atlas of the Developing Mouse Brain [45]).
ImageJ software (National Institutes of Health) was used for
unbiased quantitative analysis of immunoreactive TREM2+ area/
mm2, using a method previously described [46]. Data were shown
as TREM2+ area/mm26 S.E.M.
Colocalization Studies
Double or triple immunofluorescent staining was used for the
characterization of cells expressing TREM2. At least three animals
from different litters were used from each immunostaining at all
ages. Briefly, sections on slides were washed with TBS-T and
incubated in BB at RT for 1 hr followed by overnight incubation
at RT with primary antibodies prepared in BB (Table 1). Samples
were rinsed in TBST and incubated for 1 hr at RT with
corresponding secondary antibodies (Table 2). For tomato lectin
(TL) labeling, samples were washed after incubation with primary
antibodies and subjected to incubation with biotinylated-TL for
2 h at 37uC. This was followed by incubation with streptavidin-
conjugated secondary antibody. Before being coverslipped with
Fluoromount GTM (0100-01, SouthernBiotech) the sections were
rinsed and nuclei stained with 49,6-diamidino-2-phenylindole
(DAPI,1:10000, D9542, Sigma Aldrich). Colocalization was
analyzed with confocal microscope D1 Axio Examiner LSM 700
(Zeiss). Final plates were composed using Adobe Photoshop CS3.
TREM2 Protein Expression in Postnatal Brain
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Statistical Analysis
Data were tested for normality (Shapiro–Wilks test) and
variance homogeneity (Levene test). Comparisons were performed
using ANOVA followed by Tukeys test or Kruskal Wallis followed
by multiple comparison test, where appropriate (Infostat Version
2013, InfoStat Group, URL:http://www.infostat.com.ar). Signif-
icance was recorded at p,0.05.
Results
Postnatal Distributions of TREM2 Show an Age-
dependant Regional Pattern
We first studied the TREM2 distribution during postnatal
development using immunohistochemistry, which is summarized
in schemes with red dots (Fig. 1B–F). A high expression of
TREM2 was not only observed in subventricular zone (svz) and
neuroephitelium but also in white matter regions, especially in
corpus callosum (cc), external capsule and fimbria. Developmental
downregulation of TREM2 was observed, showing a faster
reduction in grey matter than in white matter, where it was
detectable till P10, almost exclusively in cc (Fig. 1F). TREM2 was
undetectable by immunohistochemistry after P10 at all regions
studied (data not shown) hence rest of the studies were carried out
till P10.
Quantification of Developmental Changes on TREM2+
Area
Quantification of TREM2+ area was performed in regions were
qualitative changes were observed and areas were the absence of
TREM2 had been previously correlated with pathologies.
TREM2+ area in eight regions were measured as shown in
Fig. 1A. The TREM2+ areas/mm2 were measured using ImageJ
software and are detailed below.
Subventricular zone and Neuroephitelium. These regions
expressed the highest level of TREM2 compared to other regions
analyzed in this study. Interestingly, the TREM2+ area is quite
small at P3 compared to later time points studied, showing
significant differences from P5 and P7 (Fig. 2A–D and 3A). The
expression of TREM2 in svz at P10 was undetectable (data not
shown). The morphology of TREM2+ cells was mainly round and
amoeboid in this region at P1 (Fig. 2A), progressing to primitive
ramified form at P7 (Fig. 2D).
Corpus callosum. The TREM2+ area in caudal cc in-
creased at P3–P7 and then decreased significantly after 10 days of
birth, disappearing completely at later ages (Fig. 2E–H and 3B).
These cells where mainly located at the edges between grey and
white matter, moreover, the morphology varied from amoeboid to
primitive ramified at all time points analyzed. TREM2 expression
shows no modulation in the rostral cc (Fig. S1A–D and 3C).
Interestingly, the TREM2+ area in caudal cingulate cc was higher
than in the rostral cc (Fig. 2E–H, S1A–D, 3B–C); indeed
depicting developmental modulation.
Fimbria. The TREM2+ area showed a peak of expression at
P3 (Fig. 2I–J and 3D), diminishing later until completely
disappearing at P10 (Fig. 2K–L and data not shown). The
expression is mainly concentrated in the upper part of the fimbria,
adjoining CA3 region of hippocampus. The morphology varied
with age as amoeboid and primitive ramified cells were present at
P1 through P5 (Fig. 2I–L). At P7, only primitive ramified and
ramified morphology were found.
Hippocampal fissure (hf). TREM2 expression was restrict-
ed to hf of the medial and ventral hippocampus without any
developmental modulation (Fig. 1, 2M–P and 3E). At P1,
Table 1. List of primary antibodies used for immunostaining.
Target antigen Host Dilution Catalogue Number, Brand
TREM-2 Sheep 1:400, 1:300 (IHC, IF) AF1729, R&D
GFAP Rabbit 1:750 Z0334, DAKO
Iba-1 Rabbit 1:500 019-19741, DAKO
DAP12 Rabbit 1:100 AB4070, Millipore
Tomato lectin Biotinylated 1:150 L0651, Sigma
PDGFRalpha Rat 1:1000 558774, BD Pharmigen
Olig2 Rabbit 1:200 18953, IBL
CD68 Rat 1:1000 MCA1957,AbD Serotec
CD86 Rat 1:200 550542, BD Pharmigen
CD206 Rat 1:500 MCA2235,AbD Serotec
MHCII Rat hybridoma 1:25 TBI-120, ATCC
CD16/32 Rat 1:500 553142, BD Pharmigen
IHC: immunohistochemistry.
IF: immunofluorescence.
doi:10.1371/journal.pone.0072083.t001
Table 2. List of secondary antibodies used for
immunostaining.
Conjugate Host Dilution
Catalogue Number,
Brand
Biotinylated Anti-sheep 1:500 BA6000, Vector
Alexa 488 Anti-sheep 1:500 A11015, Invitrogen
Alexa 568 Anti-rabbit 1:500 A10042, Invitrogen
Cy5 Anti-rabbit 1:500 A10523, Invitrogen
Alexa 594 Anti-rat 1:500 A21209, Invitrogen
Streptavidine - Cy5 1:500 PA45001, Amersham
Biosciences
Streptavidine - HRP 1:500 SA-5004, Vector
doi:10.1371/journal.pone.0072083.t002
TREM2 Protein Expression in Postnatal Brain
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TREM2 was expressed by some microglia/macrophages inside
and around the blood vessels of hf; however, their expression
diminished with age (Fig. 2M–P).
Cortex and Caudate-Putamen (cp). At P1, scattered
expression of TREM2 was observed with the cells being very
dispersed and limited to layers III to VI of the cortex and to dorsal
region of cp (Fig. S1E and S1I). The TREM2+ area in cortex was
maximum at P3, showing significant differences with respect to
later time-points analyzed (Fig. S1F–H and Fig3F). The
morphology of TREM2+ cells changed from primitive ramified
at P1 to ramified at P7, accompanied by a reduction in TREM2
intensity (Fig. S1E–L). No modulation of TREM2 expression was
observed in cp during postnatal development (Fig. S1I–L and
Fig 3G).
Thalamus. As in other grey matter regions, TREM2+ area
increased from P1 to P3 and then slowly disappeared at P10 (Fig. 1,
S1M–P). Significant differences appeared between P1–P3 and P7
mice in this region (Fig. 3H). Although, amoeboid TREM2+ cells
persisted at each time point analyzed, primitive ramified cells
appeared from P1 to P5 (Fig. S1M–O).
Postnatal Brain Expressed Functional TREM2
In order to determine the functional state of TREM2, we
analyzed the expression of DAP12 and its colocalization with
TREM2+ cells in postnatal brain from P1 to P7. Confocal analysis
demonstrated that almost all TREM2+ cells colocalized with
DAP12 (Fig. 4A–C) in each region and time-point studied,
especially at P1 when the highest intensity of DAP12 expression
was observed. The presence of ‘‘foamy cells’’ (arrowheads in
Fig. 4A) suggests phagocytic activity at this time-point. In addition
to membranous expression, we found that TREM2 was also
intracellularly located in some cells (arrows in Fig. 4B–C).
Lineage of TREM2+ Cells
To characterize cells expressing TREM2 protein during
postnatal development, we performed double/triple immunoflu-
orescence for markers of microglia (Iba-1, CD68, TL), oligoden-
drocyte (olig2 and PDGFRalpha), astrocytes (GFAP) and endo-
thelial cells (TL). Confocal analysis for colocalization
demonstrated that TREM2 protein was expressed by microglia/
macrophages during normal postnatal development (Fig. 5). We
Figure 1. Distribution of TREM2 protein during postnatal development. A). Schemes showing the regions quantified for TREM2 by
immunohistochemistry: 1-Cortex; 2-Caudate-Putamen; 3-Rostral Corpus callosum; 4-subventricular zone; 5-Caudal corpus callosum; 6-fimbria; 7-
hippocampal fissure and 8-thalamus. (B-F) Patterns of TREM2 expression were depicted as red dots in schemes showing rostral and caudal region of
postnatal brains at P1 (B), P3 (C), P5 (D), P7 (E) and P10 (F).
doi:10.1371/journal.pone.0072083.g001
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did not find any colocalization with oligodendrocyes (Fig. S2),
astrocytes (Fig. 5A–B) or endothelial cells (Fig. 5C–F). No
noticeable association of TREM2+ cells with the radial glia
(Fig. 5A–B) or blood vessels (Fig. 5C–F) was observed. A marker
for phagocytic activity (CD68) was expressed throughout the
parenchyma, but only a subpopulation of CD68+ cells colocalized
with TREM2.
As brain developed, there was an increase in number of
microglia although a decrease in TREM2 expression was
observed. It is noteworthy that all TREM2+ cells were microg-
lia/macrophages in each region/time analyzed (Fig. 5A–F).
Nevertheless, the Iba1+/TREM2+ cells were consistently reduced
in grey matter at P7 along with a decrease in CD68+/TREM2+
cells.
Phenotypic Characterization of TREM2+ Cells
With the purpose of analyzing the phenotypic features of
postnatal TREM2+ cells, we studied the coexpression of TREM2
in cells expressing mannose receptor (CD206), Fc receptor
(CD16/32) and antigen presentation markers (CD86 and
MHCII).
Subventricular zone. The neurogenic niche showed specific
features in microglia phenotype. Interestingly, only a subpopula-
tion of TREM2+ cells expressed CD206 and CD86 (Fig. 6A, B, E
and F). Additionally, CD16/32 and MHCII expression in
TREM2+ cells persisted during postnatal development in the
svz, though at lower levels than in other regions at all ages studied
(Fig. 6C, D, G and H).
Cingulate cortex. At P1, the microglia were dispersed; in
contrast to P7, when cells were found in all layers of the cortex,
with processes covering almost all the parenchyma (data not
shown). The colocalization of TREM2 with CD206 was observed
in meningeal and perivascular TREM2+ macrophages (Fig. S3A
and B); however, the intensity of staining on microglia was lower
in the parenchyma and almost disappeared during postnatal
development. CD16/32, CD86 and MHCII were also differen-
tially regulated on TREM2+ cells during postnatal development.
Although CD16/32 (Fig. S3C and D) and costimulatory molecule
CD86 (Fig. S3E and F) were expressed at low levels in every time-
point studied, the expression of MHCII on microglia was higher at
P1 than at P7 (Fig. S3G and H). Noticeably, the expression of
Figure 2. TREM2 immunostaining showing developmental modulation. (A–D) Developmental changes in subventricular zone (svz) at P1 (A),
P3 (B), P5 (C) and P7 (D), showing a reduction in TREM2 expression at P3 and then an increase from P5 to P7. (E–H) Developmental changes in caudal
corpus callosum (cau cc) at P1 (E), P3 (F), P5 (G) and P7 (H), showing maximum TREM2 expression at P3 followed by a progressive reduction till P7.
(I–L) Changes in fimbria (fim) at P1 (I), P3 (J), P5 (K) and P7 (L), with a maximum expression at P3. (M–P) Developmental expression of TREM2 in
hippocampal fissure (hf) at P1 (M), P3 (N), P5 (O) and P7 (P), showing no modulation of TREM2. lv: lateral ventricle; hp: hippocampus; CA1:cornu
ammonis 1. Scale bar = 50 mm.
doi:10.1371/journal.pone.0072083.g002
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Figure 3. TREM2 expression was differentially modulated in a region and age dependent manner. Quantification of TREM2+ area/mm2
in subventricular zone, SVZ (A); caudal corpus callosum, cc (B); rostral Corpus callosum (C); fimbria, FIM (D); hippocampal fissure, Hf (E); Cortex, Cx (F);
Caudate Putamen, CP (G) and thalamus, Tl (H). Three to five animals were used at each time point. Data were represented as mean 6 SEM. Analysis
was performed using one-way ANOVA followed by Tukey post hoc test or Kruskal Wallis followed by multiple comparison tests as suitable. *p,0.05;
**p,0.01; ***p,0.001.
doi:10.1371/journal.pone.0072083.g003
TREM2 Protein Expression in Postnatal Brain
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MHCII was not restricted to plasma membrane but appeared to
be cytoplasmatic also (arrows in Fig. S3H).
Caudal corpus callosum. The expression pattern of pheno-
typic markers on TREM2+ microglia were differentially regulated
in cc during the first week of postnatal development. The
TREM2+/CD206+ microglia were present here at P1 (Fig. 7A).
Although, some microglia were TREM2+ till P10 the expression
of CD206 was lost with brain maturity (Fig. 7B and data not
shown). A similar scenario was observed in this region for CD86
(Fig. 7C and 7D). Interestingly, expression of CD16/32 and
MCHII remained constant in all TREM2+ microglia during the
first week of life (Fig. 7E–H).
Fimbria. At P1, microglia expressed all markers studied (Fig.
S4A, C, E and G); however, they were independently modulated
during postnatal development. Although expression of CD206 in
parenchymal microglia was found at P1, the intensity reduced at
P7 (Fig. S4B). It is noteworthy that CD206+/TREM2- cells were
found inside the ventricles and ventricle linings at P7. Though the
expression of CD16/32 was maintained in all microglia cells (Fig.
S4D), CD86 was restricted to a subpopulation of microglia (Fig.
S4F). The same pattern was observed for MHCII+ cells (Fig.
S4H).
Hippocampal fissure. The expression of TREM2 was
restricted to perivascular macrophages and some microglial cells
at P1. The expression of CD206 was limited to perivascular
macrophages and few of them colocalized with TREM2 at P1
(Fig. 8A). TREM2+/CD206+ cells were not observed in the
parenchyma at later timepoints (Fig. 8B). Developmental modu-
lation of CD16/32, CD86 and MHCII was also found in this
region, where they co-expressed with TREM2+ microglia at P1.
However, TREM2 co-expressed with a sub-population of CD86+
and CD16/32+ cells at later time points (Fig. 8C–F). MHCII+-
TREM2+ cells were only present at P1 (Fig. 8G) and P3 (data not
shown), later being undetectable (Fig. 8H).
To highlight the phenotypes of TREM2+ cells that changed in a
region- and age-dependent manner, we summarized our findings
in Figure 9, showing a qualitative description of these changes.
Discussion
The goal of current study was to describe the regional and
temporal expression of TREM2 protein during postnatal devel-
opment as this is the first work of its type. Immunohistochemistry
for demonstration of TREM2 allowed us to characterize regional
phenotypes regulated by brain maturation. TREM2 was differen-
tially regulated in grey matter and white matter during develop-
ment. While TREM2 protein was not detected in grey matter after
P5, it was still expressed in corpus callosum at P10. In previous
studies from whole brain extracts, expression of TREM2 mRNA
has shown little or no changes in their expression level from
embryonic to adult brain [27,33]. These discrepancies in results
might be due to a post- transcriptional/translational regulation of
TREM2 or the sensitivity of the technique used. Zhao and co-
workers [47] had recently described the regulation of TREM2 by
a NF-kB-sensitive miRNA as a mechanism of TREM2 control in
Alzheimers disease patients. Whether this system is functional
during postnatal development needs to be studied.
To determine the phenotype of the TREM2+ cells during
postnatal development double or triple immunofluorescence was
performed. The study monitored colocalization of TREM2 with
astrocytes, oligodendrocytes, endothelial cells or microglia so as to
confirm previous work in adult brain [26]. In this study, all cells
expressing TREM2 protein were microglia. Some reports have
shown TREM2 expression on oligodendrocytes [27,31,32,33];
although we have not seen any such colocalization in neonatal
mice brain. Regional differences in TREM2 pattern were
observed in grey and white matter during postnatal development
in concordance with previous study in adults analyzing TREM2
mRNA [26].
Our results show DAP12 (coreceptor for TREM2) expression in
almost all TREM2+ cells analyzed suggesting a complete system
for functional signals. In accordance with our results, DAP12 was
previously described as being restricted to microglia in postnatal
CNS [34,35]. Similar to previous in vitro report in microglia [48]
showing two different pools of TREM2 that shuttled to and from
plasma membrane.
TREM2-DAP12 coexpression and TREM2+CD68+ ‘foamy’
microglia/macrophages were observed throughout development
in the svz, the region with higher expression of TREM2 in our
study. Previous studies report that TREM2 expression increase
after injury induced cell death in adults [43,44,49] and that
DAP12 is involved in neuronal apoptosis during development
[34]. Moreover, the interaction of progenitors with astrocytes and
microglia in svz leads to progenitor fate recognition [50,51]. Our
findings suggest the putative role of TREM2-DAP12 in clearance
of overproduction of cells and cell debris. Whether this complex
plays a role in the fate of progenitors in the svz needs further
elucidation.
During the first week of life, the microglia transform from
round/amoeboid to a ramified morphology while reaching their
final destination. We observed that the round or amoeboid
Figure 4. Expression of functional TREM2–DAP12 cells in postnatal brain. Immunofluorescence study of TREM2 (green), coreceptor DAP12
(red), and nuclear stain DAPI (blue) was performed. Colocalization of TREM2 and DAP12 was found in subventricular zone, SVZ (A), corpus callosum,
cc (B) and fimbria, fim (C). ‘‘Foamy’’ cells (arrowheads) and intracellular aggregation of TREM2 (arrows) was also observed. Colocalization can be seen
in yellow. Scale bar A–C=20 mm.
doi:10.1371/journal.pone.0072083.g004
TREM2 Protein Expression in Postnatal Brain
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Figure 5. TREM2 expression was found on microglia. Triple immunofluorescence was performed to characterize the population of TREM2+
cells. (A–B) TREM2 colocalized with CD68+ cells, a marker of phagocytic activity but not with radial glia or astrocytes (GFAP+ cells) at P3 in
subventricular zone, SVZ (A) and fimbria, fim (B). Insets beside the figures show separated channels: CD68 in red, TREM2 in green and GFAP in blue.
(C–F) TREM2+ cells colocalized with Iba-1+ cells but not with blood vessels. At P1, all Iba-1+ cells expressed TREM2 in SVZ (C) and fimbria (E). The
expression of TREM2 was restricted to a subpopulation of microglia at P7 (D and F). Insets in C–F represent separated channels: Iba1 in red, TREM2 in
green and Tomato lectin (TL) in blue. Triple colocalization can be seen in purple. Scale bar A–B= 50 mm; C–F= 20 mm.
doi:10.1371/journal.pone.0072083.g005
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TREM2+ microglia progressively disappeared in grey matter as
the TREM2- ramified morphology was acquired. Since ligands for
TREM2 has been described on astrocytes [25] and some reports
also suggest that astrocytes play an important role in determining
the mature microglial phenotype [52,53,54]. We hypothetized that
signals derived via TREM2 ligand-receptor interactions might
modulate the microglial phenotype in neonatal brain.
The morphological differentiation of microglia/macrophages is
usually accompanied by changes in their immunophenotype
[55,56], which reflect the functional state of microglia. Although
the classification of these phenotypes has been extensively
described in the adult CNS, the spatio-temporal regulation of
postnatal microglia has been partially understood [8,57,58].
Unlike other myeloid cells, postnatal microglia remain in an
Figure 6. Phenotypic characterization of TREM2+ microglia in subventricular zone. TREM2 co-expression with: CD206 (A–B), CD16/32 (C–
D), CD86 (E–F) and MHCII (G–H) was studied at P1 (A, C, E and G) and P7 (B, D, F and H). Insets beside each figure represent separated channels:
CD206, CD16/32, CD86 and MHCII in red, TREM2 in green and Iba1 in blue. SVZ: subventricular zone. Triple colocalization can be seen in purple. Scale
bar for A and B=50 mm; scale bar for C–H= 20 mm.
doi:10.1371/journal.pone.0072083.g006
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undifferentiated state [59]; hence, to decipher the involvement of
TREM2 during maturation we analyzed various microglial
markers. Regional differences on microglia phenotype in healthy
[17,60,61] and injured brain has been thoroughly investigated
[62,63,64]; but there is scarcity of data regarding TREM2+
microglia in neonates. We choose to monitor molecules as CD68,
MHCII and CD86 usually associated with pathologies in
TREM2+ microglia/macrophages during normal development
to deduce if they are playing a part in the active phagocytosis
happening during the first week of life when TREM2 expression
was notable.
Figure 7. Phenotypic characterization of TREM2+ microglia in corpus callosum. TREM2 co-expression with: CD206 (A–B), CD16/32 (C–D),
CD86 (E–F) and MHCII (G–H) was studied at P1 (A, C, E and G) and P7 (B, D, F and H). Insets beside each figure represent separated channels: CD206,
CD16/32, CD86 and MHCII in red, TREM2 in green and Iba1 in blue. cc: corpus callosum. Triple colocalization can be seen in purple. Scale bar for A and
B =50 mm; scale bar for C–H=20 mm.
doi:10.1371/journal.pone.0072083.g007
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TREM2 is upregulated by IL-4 [40] and has been proposed as a
marker for protective function of microglia. Also, IL-4-activated
microglia have been shown to be pro-neurogenic [62,65] and
neuroprotective [58]. IL-4 is expressed in several regions of
postnatal brain [66] and stimulates alternative activation markers
such as CD206 [58]. In this regard, we have observed a region- and
age-dependent modulation of TREM2+CD206+ cells during early
(P1–P3) postnatal development possibly affecting excessive apopto-
sis at this stage. Our results suggest that TREM2+ postnatal
microglia are endowed with more of an anti-inflammatory/
protective phenotype (CD206+).
Figure 8. Phenotypic characterization of TREM2+microglia in hippocampal fissure. TREM2 co-expression with: CD206 (A–B), CD16/32 (C–
D), CD86 (E–F) and MHCII (G–H) was studied at P1 (A, C, E and G) and P7 (B, D, F and H). Insets beside each figure represent separated channels:
CD206, CD16/32, CD86 and MHCII in red, TREM2 in green and Iba1 in blue. hf: hippocampal fissure. Triple colocalization can be seen in purple. Scale
bar for A and B=50 mm; C–H= 20 mm.
doi:10.1371/journal.pone.0072083.g008
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In accordance with our observation, it has been shown that the
expression of MHCII on microglia in the parenchyma appears
both cytoplasmatic and associated with membrane [67]. Addi-
tionally, it has been demonstrated that TREM2 increased the
expression of MHCII and CD86 in dendritic cells [30] but no
changes have been observed on cultured microglia overexpressing
TREM2 [41]. Our observation that these markers in microglia
were downregulated faster in grey matter than in white matter,
correlates with the study by Dalmau and colleagues [7] showing
microglia attaining maturity earlier in grey matter. Throughout
the first week when microglia are distributing in the parenchyma
and actively performing apoptosis, some TREM2+ cells also
express MHCII and CD86 in specific regions. Thus, we may
assume that this change of phenotype and typical regional
distribution shown by TREM2+ cells may be involved in
proliferation of microglial precursors in the developing brain. It
has been previously predicted that microglial proliferation is a
physiological mechanism contributing to the acquisition of the
adult microglial cell population [4]. Although the expression of
TREM2 diminished from P5 onwards, except in svz; CD206,
CD86, CD16/32 and MHCII were still present, at least in a
subpopulation of microglia. Nevertheless, the functional implica-
tion of these changes in the phenotype of TREM2+ cells are not
known yet.
Recently, the role of microglia and perinatal inflammation has
been associated with certain psychiatric disorders [38,68,69,70]
while loss-of-function mutation of TREM2 has been associated
with several neurodegenerative disorders or dementia
[71,72,73,74]. Therefore, the regional differences in TREM2+
microglia phenotype during postnatal development along with
other genetic or environmental factors might be involved in
pathological manifestations throughout life. Finally, as microglia
share some markers during healthy brain development and after
an injury, the understanding on the control of microglial response
during development opens new targets for microglial modulation
after injury, especially in neonates.
Conclusions
Microglia are involved not only in monitoring the brain
parenchyma, cleaning the cell debris and synaptic contacts
overproduced but also in maintaining the brain homeostasis.
The TREM2-DAP12 complex is essential for brain as loss-of-
function of one of these proteins produces an imbalance in brain
homeostasis leading to diseases. This study suggests a putative role
in control of spatio-temporal distribution of this complex during
postnatal development. We observed that TREM2 was expressed
during first week in grey and white matter; however, after this
period it was only present in white matter till P10. We also
observed phenotypic changes in TREM2+ cells with age and
region, suggesting that the microglial population is heterogenic. It
is noteworthy that different phenotypes of TREM2+ microglial
cells coexist in the same region. The increase of TREM2 in several
pathologies may recapitulate their function during postnatal
development, so the better understanding of this period can open
new pathways for future therapies.
Supporting Information
Figure S1 Developmental expression of TREM2. (A–D),
developmental expression of TREM2 in rostral corpus callosum
(ros cc) at P1 (A), P3 (B), P5 (C) and P7 (D), showing no difference
in expression pattern. (E–H) Changes in cortex (cx) at P1 (E), P3
(F), P5 (G) and P7 (H), showing a progressive reduction in TREM2
expression from P3. (I–L) TREM2 expression in caudate-putamen
(cp) at P1 (I), P3 (J), P5 (K) and P7 (L), showing no changes. (M–P)
TREM2 expression in thalamus (tl) at P1 (M), P3 (N), P5 (O) and
P7 (P), showing a progressive reduction on TREM2 expression
after P3. Scale bar = 50 mm.
(TIF)
Figure S2 TREM2 expression was not observed in oligoden-
drocytes. Double immunofluorescence was performed for coloca-
lization study of TREM2 (green) with (A) olig2 (red), a pan marker
of oligodencrocytes and (B) PDGFRalpha (red), a marker for early
oligodendrocyte progenitors. No expression of TREM2 was
observed in oligodendrocytes at any time or region studied. DAPI
was used for nuclear staining (blue) Scale bar = 20 mm.
(TIF)
Figure S3 Phenotypic characterization of cortical TREM2+
microglia. TREM2 co-expression with: CD206 (A–B), CD16/32
(C–D), CD86 (E–F) and MHCII (G–H) was studied in cortex at P1
(A, C, E and G) and P7 (B, D, F and H). Insets beside each figure
represent separated channels: CD206, CD16/32, CD86 and
MHCII in red, TREM2 in green and Iba1 in blue. Triple
colocalization can be seen in purple. Arrows represent cytoplas-
matic expression of MHCII. Cx: cortex; Scale bar for A and
B=50 mm; scale bar for C–H=20 mm.
(TIF)
Figure S4 Phenotypic characterization of TREM2+ microglia in
fimbria. TREM2 co-expression with: CD206 (A–B), CD16/32
(C–D), CD86 (E–F) and MHCII (G–H) was studied at P1 (A, C, E
and G) and P7 (B, D, F and H). Insets beside each figure represent
separated channels: CD206, CD16/32, CD86 and MHCII in red,
Figure 9. Schematic summary of spatio–temporal changes in
TREM2 phenotypes. Developmental regulation of the TREM2+
phenotypes was shown in subventricular zone (A), cortex (B), corpus
callosum (C) and fimbria (D) from P1 to P10. Regional changes in
markers associated with TREM2 (red) where represent as color intensity:
CD206 (green), CD16/32 (purple), CD86 (blue) and MHCII (orange).
doi:10.1371/journal.pone.0072083.g009
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TREM2 in green and Iba1 in blue. Triple colocalization can be
seen in purple. fim: fimbria. Scale bar for A and B= 50 mm; scale
bar for C–H=20 mm.
(TIF)
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